Aebi Schmidt (AEBI) Q2 2026 earnings review
Strong Operational Rebound Validates H2 Ramp-Up Thesis
Aebi Schmidt delivered a robust Q2, silencing concerns from a seasonally weak Q1. The narrative of temporary ramp-up investments is playing out as promised: Net Sales grew 9% YoY to $496 million, while Adjusted EBITDA surged 22% to $42.1 million. The successful conversion of the Walk-in Van backlog in North America was the primary catalyst, flipping the segment from a Q1 margin drag to a Q2 profit driver. Net Income reversed dramatically to positive $10.5 million (up from a $7.9 million loss a year ago). However, management subtly walked back its year-end deleveraging target to protect supply chain stability, indicating cash flow demands remain high to support this growth.
🐂 Bull Case
The operational ramp-up for Walk-in Vans is complete. North America delivered 11% organic sales growth and a 22% jump in Adjusted EBITDA, proving the execution thesis is intact.
Order Intake jumped 16% YoY to $516 million, driving Order Backlog to a record $1.28 billion (+20% YoY). The company has essentially locked in its H2 2026 revenue requirements.
🐻 Bear Case
The target to end FY26 with net debt leverage at or below 2.0x was revised to '2.0x or slightly above.' This signals higher-than-expected working capital investments to protect supply chains.
To achieve the $2.05 billion midpoint for FY26 sales, the company must generate approximately $1.1 billion in H2, representing a heavy, execution-intensive back-half weighting.
⚖️ Verdict: 🟢
Bullish. The company successfully executed its Q1 promise: ramp up production capacity and then convert the massive order backlog. The over-proportional growth in EBITDA (+22%) versus Sales (+9%) proves that merger synergies and operational efficiencies are sticking.
Key Themes
North America Resurgence: From Drag to Driver
After a Q1 where North America saw Adjusted EBITDA margins compress by 40 bps due to new facility ramp-up costs, the segment is now accelerating. North American Net Sales grew 11% organically, and Adjusted EBITDA jumped $6.3 million (+22% YoY) to $35.5 million. Management explicitly attributed this to successful Walk-in Van backlog conversion following the completion of production ramp-ups, augmented by strong Service Body and Airport performance.
Europe/RoW Margin Excellence
The Europe and Rest of World (RoW) segment continues to be a high-quality profit engine. While sales grew a solid but modest 7% YoY, Adjusted EBITDA surged 25% YoY to $6.6 million. The company is extracting significant operating leverage here, driven by higher gross margins in both new equipment and highly profitable aftermarket sales, combined with strict cost discipline.
Synergies and Structural Efficiency Flow-Through
The group is proving that the Shyft integration (now lapping its one-year anniversary) is yielding real structural benefits. Adjusted EBITDA grew 22%—massively outpacing the 9% sales growth. The overall Adjusted EBITDA margin expanded to 8.5% (from 7.6% a year ago). Simultaneously, Net Working Capital declined 4% to $449 million despite the sales expansion, a rare feat in a capital-intensive manufacturing ramp-up.
Deleveraging Timeline Pushed Right
Management stated that 'ongoing deleveraging' is occurring, yet contradicted this optimism by quietly walking back their leverage guidance. The prior target of exiting 2026 at or below 2.0x was revised to '2.0x or slightly above.' Management cited 'temporary investments in securing our supply chain and protecting our margins.' This indicates that inventory buffers are soaking up cash flow that was originally earmarked for debt paydown.
Macro: Vulnerability to Geopolitical and Tariff Pressures
Management explicitly tied their reaffirmed full-year guidance to the 'continued normalization of geopolitical uncertainty, tariff discussions and related inflationary pressures.' This phrasing acts as a defensive caveat. If global trade tensions escalate (particularly regarding tariffs on commercial vehicles or steel/components), the company's carefully orchestrated margin expansion and supply chain investments could face severe headwinds.
Heavy Reliance on H2 Execution
Despite the strong Q2, the math for H2 remains demanding. H1 2026 Net Sales total roughly $952 million. To hit the midpoint of their $1.95B-$2.15B guidance, the company must generate ~$1.098 billion in the second half. While the $1.28 billion backlog provides the raw material, executing at this elevated throughput rate without hitting new operational bottlenecks is a risk.
Other KPIs
Accelerating. Up 20% YoY and growing sequentially from $1.258 billion at the end of Q1. The $516 million in Q2 Order Intake (+16% YoY) heavily outpaced the $496 million in Q2 revenue, meaning the company is still building backlog even as it ramps up production.
Stable. Decreased slightly by $5 million sequentially from Q1 ($454.8 million). Leverage improved to 2.72x (down from 2.88x in Q1 and 3.28x a year ago), largely driven by LTM EBITDA expansion rather than aggressive nominal debt paydown.
Guidance
Confirmed. At the $2.05B midpoint, this implies a 7.5% YoY growth over the $1.907B achieved in FY25. With H1 sales at ~$952M, H2 needs to deliver ~$1.1B, implying an acceleration in the back half, heavily reliant on sustained Walk-in Van conversion.
Confirmed. The midpoint ($185M) implies an 18.6% YoY growth over FY25's $156M, and an implied full-year margin of ~9.0%. With H1 EBITDA at ~$75.2M, H2 must deliver ~$109.8M, representing a massive sequential margin acceleration into the back half of the year.
Decelerating expectation. Previously guided to '<= 2.0x'. The company requires supply chain investments to protect margins during the H2 production ramp, which will tie up working capital and limit absolute debt reduction.
Key Questions
Supply Chain Investments
You altered your leverage guidance due to 'temporary investments in securing our supply chain.' Which specific components or materials are requiring these buffer inventories, and when do you expect this working capital to unwind?
Commercial Segment Health
In Q1, you noted softness in the commercial business segment as a swing factor for H2. Did the commercial truck body market show signs of stabilization in Q2, or is the current growth entirely carried by Walk-in Vans, Municipal, and Airport?
Tariff Mitigation
Your guidance explicitly assumes no major disruptions from tariff discussions. Given current geopolitical rhetoric, what concrete steps (pricing power, alternative sourcing) have been established to protect gross margins if broad tariffs are implemented?